Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
0.1600
0.00 (0.00%)
Jan 22, 2026, 9:30 AM EST
Orgenesis Employees
Orgenesis had 146 employees as of December 31, 2023. The number of employees decreased by 21 or -12.57% compared to the previous year.
Employees
146
Change (1Y)
-21
Growth (1Y)
-12.57%
Revenue / Employee
$6,158
Profits / Employee
-$235,699
Market Cap
1.52M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2023 | 146 | -21 | -12.57% | 146 | 0 |
| Dec 31, 2022 | 167 | 16 | 10.60% | 167 | 0 |
| Dec 31, 2021 | 151 | 40 | 36.04% | 151 | 0 |
| Dec 31, 2020 | 111 | -198 | -64.08% | 111 | 0 |
| Dec 31, 2019 | 309 | 206 | 200.00% | 309 | 0 |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Nov 30, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Carisma Therapeutics | 46 |
| International Stem Cell | 32 |
| Evofem Biosciences | 32 |
| ZyVersa Therapeutics | 7 |
| Galera Therapeutics | 3 |
| Avenue Therapeutics | 2 |
Orgenesis News
- 11 months ago - Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies - Accesswire
- 1 year ago - Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings - Accesswire
- 1 year ago - Orgenesis GAAP EPS of $1.93, revenue of $0.3M - Seeking Alpha
- 1 year ago - Why Orgenesis (ORGS) Stock Is Down 23% Today - Benzinga
- 1 year ago - Orgenesis announces 1-for-10 reverse stock split to regain Nasdaq compliance - Seeking Alpha
- 1 year ago - Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia - GlobeNewsWire
- 1 year ago - Orgenesis Announces Strategic Partnership with Harley Street Healthcare Group to Launch a State-of-the-Art Longevity & Wellness Initiative Globally - GlobeNewsWire
- 1 year ago - Orgenesis Provides Business Update for the First Quarter of 2024 - GlobeNewsWire